Business Wire

Kinaxis Unveils 2026 Customer Award Winners at Kinexions in Las Vegas

4.6.2026 13:00:00 CEST | Business Wire | Press Release

Share

Kinaxis® (TSX: KXS), a global leader in end-to-end supply chain planning and orchestration, today announced the winners of its 2026 Customer Awards. Now in their eighth year, these awards were celebrated live at Kinexions North America, the flagship premiere global conference hosted by Kinaxis, bringing together supply chain leaders from around the world.

The annual awards spotlight organizations and individuals who are redefining what’s possible in modern supply chains. The winners are driving innovation, responding with agility, and delivering real business results with the Kinaxis Maestro™ platform. The awards recognized seven leading companies including Reckitt, General Motors, Lupin, Jabil, and Cardinal Health among the full list of winners. Additionally, Praveen Vasudevan (Bio-Rad Laboratories) received the champion award for their industry contributions.

“Kinexions is where the best of the best in supply chain come together, and our customer award winners represent exactly what that excellence looks like in action,” said Razat Gaurav, CEO at Kinaxis. “These organizations aren’t just navigating complexity; they’re turning it into competitive advantage, using AI-driven planning and decisioning to drive measurable impact across their operations with support from Kinaxis. Their leadership, innovation, and results are setting a new benchmark for what’s possible in modern supply chains and we’re proud to recognize them on this global stage.”

2026 Kinaxis Customer Award Winners

  • Pioneer Award: Reckitt
    Recognizes organizations demonstrating a clear implementation journey and measurable supply chain impact across service, inventory, lead times, and planning performance. Recognized as a pioneer through early adoption of enterprise scheduling and the rapid implementation of demand, supply, inventory, and enterprise planning capabilities, with Kinaxis Maestro serving as the core foundation of Reckitt’s modern supply chain technology stack.
  • Champion Award: Praveen Vasudevan, BioRad Laboratories
    Honors individuals demonstrating leadership, vision, and perseverance in supply chain transformation.
    Praveen Vasudevan was recognized as a deep technical and business champion who navigates the intense complexities of the AI, life sciences, and supply chain intersection. He successfully transformed foundational data models to elevate customer-driven planning into a strategic, enterprise‑wide decision capability, directly enabling the seamless forecasting and distribution of critical medical technologies in the life sciences industry.
  • Excellence Award: General Motors
    Awarded for measurable business impact through supply chain strategy.
    Recognized for excellence in supply chain strategy and orchestration, General Motors modernized end-to-end service parts planning with Kinaxis Maestro—enabling concurrent planning, faster disruption response, and improved product availability while protecting profitability and cash flow.
  • Impact Award: Lupin Limited
    Recognizes positive environmental and social contributions.
    Recognized for leading with purpose and delivering measurable results for people and the planet. Lupin leveraged a unified planning platform across 130+ countries to reduce waste and emissions, boost employee wellbeing through automation, and expand patient access through more resilient, predictive supply chain decisions.
  • Innovation Award: Jabil
    Highlights innovative applications of Kinaxis technology.
    Recognized for innovation leadership, Jabil is an early adopter of advanced AI, machine learning forecasting, optimization, and risk intelligence—actively innovating and piloting emerging capabilities to improve planning efficiency, forecast accuracy and long‑term inventory outcomes.
  • Center of Excellence Catalyst Award: Cardinal Health
    Recognizes customers who leverage a Kinaxis Center of Excellence to accelerate adoption and scale value.
    Cardinal Health’s Global Medical Products and Distribution business is recognized for building a disciplined IT and Business Center of Excellence (COE) that standardizes best practices and drives scalable capabilities — positioning Kinaxis for optimal use within supply chain operations. By connecting business and IT, the COE helps drive real-time visibility, more proactive decision-making and improved service levels for customers.

“Our customers continue to set the pace for what modern supply chains can achieve,” said Mike Mauger, Chief Customer Officer at Kinaxis. “Each of this year’s winners is translating strategy into execution and leveraging Kinaxis Maestro to drive faster decisions, improve resilience, and deliver measurable outcomes across their operations. What stands out is not just their innovation, but their ability to turn that innovation into real impact for their business, their customers, and their industries. We are proud to play a part in their success.”

Partner Excellence Supporting Customer Success

Kinaxis also continues to invest in its partner ecosystem, an essential force behind customer success and innovation. Earlier this year at the annual Ignite Sales Kickoff event in Fort Lauderdale, Florida, Kinaxis honored its top partners for outstanding performance and collaboration in 2025:

Top Global System Integrator: Genpact
Top Strategic Partner: 4flow
Top VAR Partner: Deloitte EMEA

Shaping the Future of Supply Chain Together

Kinexions is the premier gathering for the global supply chain community and brings together a community of innovators, leaders, and experts committed to advancing the future of supply chain planning and orchestration. This year’s award winners reflect a broader industry shift toward smarter, faster, and more connected decision-making, powered by AI, real-time data, and end-to-end orchestration.

To learn more about how Kinaxis is revolutionizing supply chain planning and orchestration with AI, please visit Kinaxis.com.

About Kinaxis

Kinaxis is a leader in modern supply chain planning and orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.

Source: Kinaxis Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260604952189/en/

Contacts

Media Relations
Erin Boyle | Kinaxis
eboyle@kinaxis.com
+1 519-574-4065

Investor Relations
Rick Wadsworth | Kinaxis
rwadsworth@kinaxis.com
613-907-7613

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Presents New Data on ALYFTREK ® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating the long-term safety and efficacy profile of the medicine. The data, presented at the European Cystic Fibrosis Conference, show children ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including those who are homozygous for the F508del mutation (F/F) and those who have F508del/minimal function mutations (F/MF)on ALYFTREK had further improvement in CFTR function from a TRIKAFTA ® baseline as measured by sweat chloride (SwCl), with 65% having achieved SwCl <30 mmol/L after treatment with ALYFTREK. Vertex also presented Phase 3 data of children ages 1 to <2 with TRIKAF

Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press Release

Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built

DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press Release

DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press Release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict

Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press Release

A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal opportunities across the Group’s production sites and communities. These are just some of the “sustainability” stories the Barilla Group is sharing on World Environment Day with the publication of its 2025 Sustainability Report. The report comes just after Barilla was named the world’s most reputable company in the food sector for the third year running and, for the first time, ranked among the global top 10 in the Global RepTrak 100 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603162436/en/ “The future of the planet will increasingly depend on our ability to spread culture and education,” says Paolo Barilla, Vic

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye